» Articles » PMID: 31482953

Thyroid Nodules ≤ 1 Cm and Papillary Thyroid Microcarcinomas: Brazilian Experts Opinion

Overview
Specialty Endocrinology
Date 2019 Sep 5
PMID 31482953
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The indolent evolution of low-risk papillary thyroid microcarcinoma (mPTC) in adult patients and the consequences of thyroidectomy require a revision of the management traditionally recommended. Aiming to spare patients unnecessary procedures and therapies and to optimize the health system in Brazil, we suggest some measures. Fine-needle aspiration of nodules ≤ 1 cm without extrathyroidal extension on ultrasonography should be performed only in nodules classified as "very suspicious" (i.e., high suspicion according to ATA, high risk according to AACE, TI-RADS 5) and in selected cases [age < 40 years, nodule adjacent to the trachea or recurrent laryngeal nerve (RLN), multiple suspicious nodules, presence of hypercalcitoninemia or suspicious lymph nodes]. Active surveillance (AS) rather than immediate surgery should be considered in adult patients with low-risk mPTC. Lobectomy is the best option in patients with unifocal low-risk mPTC who are not candidates for AS because of age, proximity of the tumor to the trachea or RLN, or because they opted for surgery. The same applies to patients who started AS but had a subsequent surgical indication not due to a suspicion of tumor extension beyond the gland or multicentricity. Molecular tests are not necessary to choose between AS and surgery or, in the latter case, between lobectomy and total thyroidectomy. The presence of RAS or other RAS-like mutations or BRAFV600E or other BRAF V600E-like mutations should not modify the management cited above; however, the rare cases of mPTC exhibiting high-risk mutations, like in the TERT promoter or p53, are not candidates for AS.

Citing Articles

Active surveillance versus immediate surgery in the management of low-risk papillary thyroid microcarcinoma: comparison of long-term costs in Brazil.

Faro F, Bertelli A, Scalissi N, Cury A, Padovani R, Ferraz C Arch Endocrinol Metab. 2024; 68:e230349.

PMID: 39420891 PMC: 11326739. DOI: 10.20945/2359-4292-2023-0349.


Impact of a simple informative leaflet on Brazilian doctors' attitudes towards active surveillance of thyroid microcarcinomas.

Duarte F, Faro F, Ward L, Cury A, Ferraz C, Padovani R Heliyon. 2024; 10(17):e37300.

PMID: 39296249 PMC: 11409082. DOI: 10.1016/j.heliyon.2024.e37300.


The predictive models based on multimodality ultrasonography for the differential diagnosis of thyroid nodules smaller than 10 mm.

Li G, Ma S, Zhang F, Jia C, Liu L, Gao F Br J Radiol. 2023; 96(1149):20221120.

PMID: 37427752 PMC: 10461269. DOI: 10.1259/bjr.20221120.


Guidelines from the Brazilian society of surgical oncology regarding indications and technical aspects of neck dissection in papillary, follicular, and medullary thyroid cancers.

Farias T, Kowalski L, Dias F, Barreira C, Vartanian J, Tavares M Arch Endocrinol Metab. 2023; 67(4):e000607.

PMID: 37252696 PMC: 10665072. DOI: 10.20945/2359-3997000000607.


Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).

Ward L, Scheffel R, Hoff A, Ferraz C, Vaisman F Arch Endocrinol Metab. 2022; 66(4):522-532.

PMID: 36074944 PMC: 10697645. DOI: 10.20945/2359-3997000000512.


References
1.
Ahn H, Kim H, Welch H . Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med. 2014; 371(19):1765-7. DOI: 10.1056/NEJMp1409841. View

2.
Veiga L, Neta G, Aschebrook-Kilfoy B, Ron E, Devesa S . Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. Thyroid. 2013; 23(6):748-57. PMC: 3675840. DOI: 10.1089/thy.2012.0532. View

3.
Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro M, De Palma M . Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest. 2018; 41(7):849-876. DOI: 10.1007/s40618-018-0884-2. View

4.
Lim H, Devesa S, Sosa J, Check D, Kitahara C . Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017; 317(13):1338-1348. PMC: 8216772. DOI: 10.1001/jama.2017.2719. View

5.
Zhang L, Zhou W, Zhan W, Peng Y, Jiang S, Xu S . Percutaneous Laser Ablation of Unifocal Papillary Thyroid Microcarcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Assessing Local Therapeutic Response. World J Surg. 2018; 42(8):2476-2484. DOI: 10.1007/s00268-018-4500-6. View